These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 811653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action.
    Morse SA, Jones BV, Lysko PG.
    Antimicrob Agents Chemother; 1980 Sep; 18(3):416-23. PubMed ID: 6775595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K, Kageyama M.
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [Abstract] [Full Text] [Related]

  • 9. Mode of action of pyocin R1.
    Iijima M.
    J Biochem; 1978 Feb; 83(2):395-402. PubMed ID: 416014
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa.
    Sano Y, Matsui H, Kobayashi M, Kageyama M.
    J Bacteriol; 1993 May; 175(10):2907-16. PubMed ID: 8491711
    [Abstract] [Full Text] [Related]

  • 12. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.
    Farkas-Himsley H, Cheung R.
    Cancer Res; 1976 Oct; 36(10):3561-7. PubMed ID: 953984
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A, Whitby JL, Wildy P.
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [Abstract] [Full Text] [Related]

  • 16. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity.
    Seo Y, Galloway DR.
    Biochem Biophys Res Commun; 1990 Oct 30; 172(2):455-61. PubMed ID: 2122894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G, Targa S, Basaglia M, Marchetti G, Crovatto M.
    Boll Ist Sieroter Milan; 1983 Jul 30; 62(3):242-6. PubMed ID: 6416270
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA, Vaughan P, Johnson D, Iglewski BH.
    Antimicrob Agents Chemother; 1976 Aug 30; 10(2):354-62. PubMed ID: 825024
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.